Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shinya Goto

Showing results (161-170 of 265) with videos related to

Pageof 27
Sort By:
Journal of Thrombosis and Thrombolysis|June 2, 2012
Atopaxar and its effects on markers of platelet activation and inflammation: results from the LANCELOT CAD programMichelle L O'Donoghue, Deepak L Bhatt, Marcus D Flather, et al.
Gut|December 12, 2013
Multinational, double-blind, randomised, placebo-controlled, prospective study of esomeprazole in the prevention of recurrent peptic ulcer in low-dose acetylsalicylic acid users: the LAVENDER studyKentaro Sugano, Myung-Gyu Choi, Jaw-Town Lin, et al.
Journal of the American Heart Association|February 9, 2018
Dyslipidemia and Risk of Cardiovascular Events in Patients With Atrial Fibrillation Treated With Oral Anticoagulation Therapy: Insights From the ARISTOTLE (Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation) TrialTymon Pol, Claes Held, Johan Westerbergh, et al.
International Journal of Cardiology|January 15, 2020
Regional variation in clinical characteristics and outcomes in patients with atrial fibrillation: Findings from the ARISTOTLE trialM Cecilia Bahit, Christopher B Granger, John H Alexander, et al.
European Heart Journal|November 13, 2012
Resistant hypertension: a frequent and ominous finding among hypertensive patients with atherothrombosisDharam J Kumbhani, P Gabriel Steg, Christopher P Cannon, et al.
JAMA|October 4, 2012
β-Blocker use and clinical outcomes in stable outpatients with and without coronary artery diseaseSripal Bangalore, Gabriel Steg, Prakash Deedwania, et al.
European Heart Journal|March 4, 2014
Statin therapy and long-term adverse limb outcomes in patients with peripheral artery disease: insights from the REACH registryDharam J Kumbhani, Ph Gabriel Steg, Christopher P Cannon, et al.
The Journal of Clinical Investigation|December 30, 2009
Lnk regulates integrin alphaIIbbeta3 outside-in signaling in mouse platelets, leading to stabilization of thrombus development in vivoHitoshi Takizawa, Satoshi Nishimura, Naoya Takayama, et al.
European Heart Journal|September 2, 2009
Three-year follow-up and event rates in the international REduction of Atherothrombosis for Continued Health RegistryMark J Alberts, Deepak L Bhatt, Jean-Louis Mas, et al.
Infection and Immunity|February 28, 2018
Prostaglandin E<sub>2</sub> Induction Suppresses the Th1 Immune Responses in Cattle with Johne's DiseaseYamato Sajiki, Satoru Konnai, Tomohiro Okagawa, et al.
Pageof 27

Showing results (161-170 of 265) with videos related to

Sort By:
Pageof 27
Journal of Thrombosis and Thrombolysis|June 2, 2012
Atopaxar and its effects on markers of platelet activation and inflammation: results from the LANCELOT CAD programMichelle L O'Donoghue, Deepak L Bhatt, Marcus D Flather, et al.
Gut|December 12, 2013
Multinational, double-blind, randomised, placebo-controlled, prospective study of esomeprazole in the prevention of recurrent peptic ulcer in low-dose acetylsalicylic acid users: the LAVENDER studyKentaro Sugano, Myung-Gyu Choi, Jaw-Town Lin, et al.
Journal of the American Heart Association|February 9, 2018
Dyslipidemia and Risk of Cardiovascular Events in Patients With Atrial Fibrillation Treated With Oral Anticoagulation Therapy: Insights From the ARISTOTLE (Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation) TrialTymon Pol, Claes Held, Johan Westerbergh, et al.
International Journal of Cardiology|January 15, 2020
Regional variation in clinical characteristics and outcomes in patients with atrial fibrillation: Findings from the ARISTOTLE trialM Cecilia Bahit, Christopher B Granger, John H Alexander, et al.
European Heart Journal|November 13, 2012
Resistant hypertension: a frequent and ominous finding among hypertensive patients with atherothrombosisDharam J Kumbhani, P Gabriel Steg, Christopher P Cannon, et al.
JAMA|October 4, 2012
β-Blocker use and clinical outcomes in stable outpatients with and without coronary artery diseaseSripal Bangalore, Gabriel Steg, Prakash Deedwania, et al.
European Heart Journal|March 4, 2014
Statin therapy and long-term adverse limb outcomes in patients with peripheral artery disease: insights from the REACH registryDharam J Kumbhani, Ph Gabriel Steg, Christopher P Cannon, et al.
The Journal of Clinical Investigation|December 30, 2009
Lnk regulates integrin alphaIIbbeta3 outside-in signaling in mouse platelets, leading to stabilization of thrombus development in vivoHitoshi Takizawa, Satoshi Nishimura, Naoya Takayama, et al.
European Heart Journal|September 2, 2009
Three-year follow-up and event rates in the international REduction of Atherothrombosis for Continued Health RegistryMark J Alberts, Deepak L Bhatt, Jean-Louis Mas, et al.
Infection and Immunity|February 28, 2018
Prostaglandin E<sub>2</sub> Induction Suppresses the Th1 Immune Responses in Cattle with Johne's DiseaseYamato Sajiki, Satoru Konnai, Tomohiro Okagawa, et al.
Pageof 27